Joy joined Prometheus’ board of directors in November 2020 and he currently serves as a Senior Research Analyst at Eventide, with a primary focus on healthcare and life sciences.
Dr. Ghosh has a cross-disciplinary background in biopharma/biotech R&D, business development/M&A, and healthcare investing. Prior to joining Eventide, from 2017-2020, Dr. Ghosh was an Associate/Vice President at Bain Capital for their Life Sciences Fund. From 2016-2017, Dr. Ghosh was a Sr. Manager at Biogen. From 2009-2016, Dr. Ghosh was an Investigator at the Novartis Institutes of Biomedical Research. Prior to Novartis, Dr. Ghosh was a postdoctoral scientist at Brigham and Women’s Hospital/Harvard Medical School and Boston University School of Medicine.
He holds a PhD from the University of Washington, Seattle in Biomolecular Structure and Design and a bachelor’s degree from the University of Texas at Austin in Biochemistry.